Clinical Trials on Postprandial Glycaemia, in Ireland

Total 4 results

University College Dublin

Active, not recruiting

Effects of Seaweed Extract on Postprandial Response to White Bread

Glucose Intolerance | Healthy Subjects | Postprandial Hyperglycemia | Glycemic Control | Diabetes Mellitus Risk

Ireland
University College Dublin

Recruiting

Effects of Seaweed Extract on Blood Glucose Response to Sucrose

Diabetes Mellitus, Type 2 | Glucose Intolerance | Healthy Diet | Postprandial Hyperglycemia

Ireland
AstraZeneca

Completed

A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control

United States, Canada, Czechia, Germany, Russian Federation, Mexico
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c Level

Czech Republic, Poland, Spain, Germany, Canada, Slovakia

3

Subscribe